Evidence map›Paper›PMID 31548808›Full record

ArticleCurrent oncology (Toronto, Ont.)2019

Lessons learned from a cancer knowledge translation grants program: results of an evaluation.

M A O'Brien, T Makuwaza, I D Graham, L Barbera, C C Earle, M C Brouwers, E Grunfeld

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M A O'BrienDepartment of Family and Community Medicine, University of Toronto, Toronto, ON.
T MakuwazaDepartment of Family and Community Medicine, University of Toronto, Toronto, ON.
I D GrahamSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON.
L BarberaTom Baker Cancer Centre, Calgary, AB.
C C EarleOntario Institute for Cancer Research, Toronto, ON.
M C BrouwersSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON.
E GrunfeldDepartment of Family and Community Medicine, University of Toronto, Toronto, ON.

Funding

CIHR FDN 143237
6 · The paper itself

Abstract

Background: A novel way to build capacity in knowledge translation (kt) is through kt-focused grant competitions. Since 2009, the Knowledge Translation Research Network (KT-Net) has had a cancer-related kt grants program. We undertook an evaluation of the program to determine if KT-Net was achieving its aims of building capacity in cancer kt, advancing the science of kt, building partnerships, and leveraging funding. Methods: An adapted framework guided the evaluation. Nine funded studies from 4 competitions were included. Semi-structured telephone interviews were held with researchers, stakeholders (including knowledge users), members of grant review panels, and experts in kt. Interview transcripts were audio-recorded, transcribed, and analyzed thematically. A review of proposal and report documents was also conducted. Results: Funded researchers indicated that the grant competition was an essential funding program for cancer kt research. Competitions were perceived to build capacity in cancer kt among early-career researchers and to encourage innovative cancer kt research for which alternative funding sources are limited. The grants program resulted in incremental gains in advancing the science of kt. Suggestions to improve the program included stronger partnerships between the funder and the provincial cancer-system organization to optimize the application of research that is relevant to the organization's strategic objectives. Conclusions: The grants program met many of its aims by providing cancer researchers with an opportunity to gain capacity in cancer kt and by making incremental advances in kt science. Suggestions to improve the program included closer partnerships between the funder and the cancer-system organization.

Indexed as

Evaluation Studies as TopicHumansNeoplasmsProgram EvaluationTranslational Research, Biomedicalcapacity buildinggrant competitionsintegrated knowledge translationKnowledge translation

Identifiers

PMID31548808
PMCPMC6726260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.